Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 105 clinical trials
Featured trial
Eltrombopag Added to Standard Immunosuppression in Treatment-Naive Severe Aplastic Anemia

Background: Severe aplastic anemia is a rare and serious blood disorder. It happens when the immune system starts to attack the bone marrow cells. This causes the bone marrow to stop making red blood cells, platelets, and white blood cells. Standard treatment for this disease is horse-ATG and cyclosporine, which …

anemia studies
anemia
myelodysplastic syndrome (mds)
myelodysplastic syndromes
aplastic anemia
  • 132 views
  • 22 Dec, 2020
  • 1 location
None
Genetic Testing for Common Disorders: Learning from the Experiences of Individuals who were Tested to Determine their Genetic Risk for Alzheimer’s Disease

genetic testing for Alzheimer’s disease risk. If you are concerned about Alzheimer’s disease or memory changes in yourself or a loved one, the Alzheimer’s Association encourages you to have a frank

Online studies
Accepts healthy volunteers
  • 281 views
  • 13 Oct, 2021
  • Online study
None
A Long-term Study to Assess the Safety and Efficacy of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).

This is an open-label long-term multicenter phase 3 trial to evaluate the efficacy and safety of ARGX-113 in adult patients with primary ITP.

  • 0 views
  • 17 Nov, 2021
  • 130 locations
None
  • 17 views
  • 05 Dec, 2021
  • 66 locations
None
  • 0 views
  • 05 Dec, 2021
  • 73 locations
None
A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia

Primary immune thrombocytopenia (ITP) is a rare disease that results in low levels of platelets - the cells that help blood clot. The main aim of the study is to check for side effects

  • 0 views
  • 30 Sep, 2021
  • 31 locations
None
  • 26 views
  • 17 Nov, 2021
  • 101 locations
None
IMG-7289 in Patients With Essential Thrombocythemia

This is a Phase 2b open label study of an orally administered LSD1 inhibitor, IMG-7289, in patients with essential thrombocythemia. This study investigates the following: The safety and tolerability of IMG-7289 The pharmacodynamic effect of IMG-7289

interferon
thrombocytosis
thrombosis
platelet count
  • 3 views
  • 31 Jul, 2021
  • 6 locations
None
Avatrombopag in Primary Immune Thrombocytopenia (ITP) in Adults

This single-center study aims to study the efficacy and safety of avatrombopag in Chinese adult ITP patients. This study will be conducted in adult ITP patients who had not responded to

  • 0 views
  • 28 May, 2021
  • 1 location
None
Immunomodulation With Eltrombopag in ITP

The study aims to investigate immunomodulatory effects of eltrombopag combined with dexamethasone in young adult patients with newly diagnosed primary Immune thrombocytopenia (ITP

  • 0 views
  • 28 Oct, 2021
  • 6 locations